Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Baosheng Li
Observed names:
B Li,
Bo Li
Institutions:
Shandong Tumor Hospital,
Shandong Provincial Hospital,
Shandong First Medical University
Observed institutions:
Shandong Tumor Hospital,
Shandong Provincial Hospital,
Shandong First Medical University
ORCID:
0009-0006-5852-7712
Observed ORCID:
0009-0006-5852-7712
OpenAlex ID:
A5136265848
Sintilimab plus concurrent chemoradiotherapy for treatment of locally advanced small cell lung cancer (SINCE-01): a phase II clinical trial
2026
·
Qian Zhao
, Yintao Li
, et al.
·
Signal Transduction and Targeted Therapy
·
4
PDF
Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial
2026
·
Yi Pan
, Xuening Yang
, et al.
·
Signal Transduction and Targeted Therapy
·
2
PDF
Induction Serplulimab and Chemotherapy Followed by Chemoradiotherapy for Bulky Unresectable Stage III NSCLC: A Phase II Study (SUCCEED-01)
2026
·
Chengxin Liu
, Yang Du
, et al.
·
Cancer Immunology Research
·
1
[Incidence of congenital hypothyroidism in preterm infants with gestational age <32 weeks and their growth and developmental outcomes at 3 years of age].
2026
·
S Zhu
, W Xu
, et al.
·
PubMed
The role of ginkgo leaf extract and dipyridamole adjuvant treatment for reduction of lower limb deep vein thrombosis after proximal femoral nail antirotation surgery in elderly patients with intertrochanteric femoral fracture
2026
·
Jianbo Xu
, Bo Li
·
Frontiers in Pharmacology
PDF
Show more works
View as search
Works count:
5
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type